A citation-based method for searching scientific literature

John A Wells, Adam R Glassman, Allison R Ayala, Lee M Jampol, Neil M Bressler, Susan B Bressler, Alexander J Brucker, Frederick L Ferris, G Robert Hampton, Chirag Jhaveri, Michele Melia, Roy W Beck. Ophthalmology 2016
Times Cited: 454







List of co-cited articles
652 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.
John A Wells, Adam R Glassman, Allison R Ayala, Lee M Jampol, Lloyd Paul Aiello, Andrew N Antoszyk, Bambi Arnold-Bush, Carl W Baker, Neil M Bressler, David J Browning,[...]. N Engl J Med 2015
868
36

Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE.
Quan Dong Nguyen, David M Brown, Dennis M Marcus, David S Boyer, Sunil Patel, Leonard Feiner, Andrea Gibson, Judy Sy, Amy Chen Rundle, J Jill Hopkins,[...]. Ophthalmology 2012
35

Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema.
Michael J Elman, Lloyd Paul Aiello, Roy W Beck, Neil M Bressler, Susan B Bressler, Allison R Edwards, Frederick L Ferris, Scott M Friedman, Adam R Glassman, Kellee M Miller,[...]. Ophthalmology 2010
918
27

Intravitreal Aflibercept for Diabetic Macular Edema: 148-Week Results from the VISTA and VIVID Studies.
Jeffrey S Heier, Jean-François Korobelnik, David M Brown, Ursula Schmidt-Erfurth, Diana V Do, Edoardo Midena, David S Boyer, Hiroko Terasaki, Peter K Kaiser, Dennis M Marcus,[...]. Ophthalmology 2016
185
26

Intravitreal aflibercept for diabetic macular edema.
Jean-François Korobelnik, Diana V Do, Ursula Schmidt-Erfurth, David S Boyer, Frank G Holz, Jeffrey S Heier, Edoardo Midena, Peter K Kaiser, Hiroko Terasaki, Dennis M Marcus,[...]. Ophthalmology 2014
456
24

Global prevalence and major risk factors of diabetic retinopathy.
Joanne W Y Yau, Sophie L Rogers, Ryo Kawasaki, Ecosse L Lamoureux, Jonathan W Kowalski, Toke Bek, Shih-Jen Chen, Jacqueline M Dekker, Astrid Fletcher, Jakob Grauslund,[...]. Diabetes Care 2012
24

The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema.
Paul Mitchell, Francesco Bandello, Ursula Schmidt-Erfurth, Gabriele E Lang, Pascale Massin, Reinier O Schlingemann, Florian Sutter, Christian Simader, Gabriela Burian, Ortrud Gerstner,[...]. Ophthalmology 2011
873
19

Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE.
David M Brown, Quan Dong Nguyen, Dennis M Marcus, David S Boyer, Sunil Patel, Leonard Feiner, Patricio G Schlottmann, Amy Chen Rundle, Jiameng Zhang, Roman G Rubio,[...]. Ophthalmology 2013
533
18

Guidelines for the Management of Diabetic Macular Edema by the European Society of Retina Specialists (EURETINA).
Ursula Schmidt-Erfurth, Jose Garcia-Arumi, Francesco Bandello, Karina Berg, Usha Chakravarthy, Bianca S Gerendas, Jost Jonas, Michael Larsen, Ramin Tadayoni, Anat Loewenstein. Ophthalmologica 2017
236
16

Intravitreal Aflibercept for Diabetic Macular Edema: 100-Week Results From the VISTA and VIVID Studies.
David M Brown, Ursula Schmidt-Erfurth, Diana V Do, Frank G Holz, David S Boyer, Edoardo Midena, Jeffrey S Heier, Hiroko Terasaki, Peter K Kaiser, Dennis M Marcus,[...]. Ophthalmology 2015
293
15

Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.
Jeffrey G Gross, Adam R Glassman, Danni Liu, Jennifer K Sun, Andrew N Antoszyk, Carl W Baker, Neil M Bressler, Michael J Elman, Frederick L Ferris, Thomas W Gardner,[...]. JAMA Ophthalmol 2018
149
14


Effect of Adding Dexamethasone to Continued Ranibizumab Treatment in Patients With Persistent Diabetic Macular Edema: A DRCR Network Phase 2 Randomized Clinical Trial.
Raj K Maturi, Adam R Glassman, Danni Liu, Roy W Beck, Abdhish R Bhavsar, Neil M Bressler, Lee M Jampol, Michele Melia, Omar S Punjabi, Hani Salehi-Had,[...]. JAMA Ophthalmol 2018
100
12

Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients With Diabetic Macular Edema Involving the Center of the Macula and Good Visual Acuity: A Randomized Clinical Trial.
Carl W Baker, Adam R Glassman, Wesley T Beaulieu, Andrew N Antoszyk, David J Browning, Kakarla V Chalam, Sandeep Grover, Lee M Jampol, Chirag D Jhaveri, Michele Melia,[...]. JAMA 2019
95
12

Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.
Jeffrey G Gross, Adam R Glassman, Lee M Jampol, Seidu Inusah, Lloyd Paul Aiello, Andrew N Antoszyk, Carl W Baker, Brian B Berger, Neil M Bressler, David Browning,[...]. JAMA 2015
387
12

Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema.
David S Boyer, Young Hee Yoon, Rubens Belfort, Francesco Bandello, Raj K Maturi, Albert J Augustin, Xiao-Yan Li, Harry Cui, Yehia Hashad, Scott M Whitcup. Ophthalmology 2014
602
12

Real-world Outcomes of Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema in the United States.
Thomas A Ciulla, Peter Bracha, John Pollack, David F Williams. Ophthalmol Retina 2018
58
18

Intravitreal Ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: 5-year randomized trial results.
Michael J Elman, Allison Ayala, Neil M Bressler, David Browning, Christina J Flaxel, Adam R Glassman, Lee M Jampol, Thomas W Stone. Ophthalmology 2015
218
10

Persistent Macular Thickening Following Intravitreous Aflibercept, Bevacizumab, or Ranibizumab for Central-Involved Diabetic Macular Edema With Vision Impairment: A Secondary Analysis of a Randomized Clinical Trial.
Neil M Bressler, Wesley T Beaulieu, Adam R Glassman, Kevin J Blinder, Susan B Bressler, Lee M Jampol, Michele Melia, John A Wells. JAMA Ophthalmol 2018
111
10

Early and Long-Term Responses to Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema: Analysis of Protocol I Data.
Victor H Gonzalez, Joanna Campbell, Nancy M Holekamp, Szilárd Kiss, Anat Loewenstein, Albert J Augustin, Julia Ma, Allen C Ho, Vaishali Patel, Scott M Whitcup,[...]. Am J Ophthalmol 2016
166
10

Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study.
Pascale Massin, Francesco Bandello, Justus G Garweg, Lutz L Hansen, Simon P Harding, Michael Larsen, Paul Mitchell, Dianne Sharp, U E K Wolf-Schnurrbusch, Margarita Gekkieva,[...]. Diabetes Care 2010
476
9

Prevalence of and risk factors for diabetic macular edema in the United States.
Rohit Varma, Neil M Bressler, Quan V Doan, Michelle Gleeson, Mark Danese, Julie K Bower, Elizabeth Selvin, Chantal Dolan, Jennifer Fine, Shoshana Colman,[...]. JAMA Ophthalmol 2014
172
9

Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis.
Gianni Virgili, Mariacristina Parravano, Jennifer R Evans, Iris Gordon, Ersilia Lucenteforte. Cochrane Database Syst Rev 2017
63
14

Three-year outcomes of individualized ranibizumab treatment in patients with diabetic macular edema: the RESTORE extension study.
Ursula Schmidt-Erfurth, Gabriele E Lang, Frank G Holz, Reinier O Schlingemann, Paolo Lanzetta, Pascale Massin, Ortrud Gerstner, Abdelkader Si Bouazza, Haige Shen, Aaron Osborne,[...]. Ophthalmology 2014
208
9

Vision Outcomes Following Anti-Vascular Endothelial Growth Factor Treatment of Diabetic Macular Edema in Clinical Practice.
Nancy M Holekamp, Joanna Campbell, Arghavan Almony, Herbert Ingraham, Steven Marks, Hitesh Chandwani, Ashley L Cole, Szilárd Kiss. Am J Ophthalmol 2018
44
18

Ranibizumab 0.5 mg treat-and-extend regimen for diabetic macular oedema: the RETAIN study.
Christian Prünte, Franck Fajnkuchen, Sajjad Mahmood, Federico Ricci, Katja Hatz, Jan Studnička, Vladimir Bezlyak, Soumil Parikh, William John Stubbings, Andreas Wenzel,[...]. Br J Ophthalmol 2016
97
8

Ranibizumab for neovascular age-related macular degeneration.
Philip J Rosenfeld, David M Brown, Jeffrey S Heier, David S Boyer, Peter K Kaiser, Carol Y Chung, Robert Y Kim. N Engl J Med 2006
8

A 2-year prospective randomized controlled trial of intravitreal bevacizumab or laser therapy (BOLT) in the management of diabetic macular edema: 24-month data: report 3.
Ranjan Rajendram, Samantha Fraser-Bell, Andrew Kaines, Michel Michaelides, Robin D Hamilton, Simona Degli Esposti, Tunde Peto, Catherine Egan, Catey Bunce, Richard David Leslie,[...]. Arch Ophthalmol 2012
252
8

Ranibizumab and bevacizumab for neovascular age-related macular degeneration.
Daniel F Martin, Maureen G Maguire, Gui-shuang Ying, Juan E Grunwald, Stuart L Fine, Glenn J Jaffe. N Engl J Med 2011
8

Early Response to Anti-Vascular Endothelial Growth Factor and Two-Year Outcomes Among Eyes With Diabetic Macular Edema in Protocol T.
Neil M Bressler, Wesley T Beaulieu, Maureen G Maguire, Adam R Glassman, Kevin J Blinder, Susan B Bressler, Victor H Gonzalez, Lee M Jampol, Michele Melia, Jennifer K Sun,[...]. Am J Ophthalmol 2018
40
20

Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab.
Nicholas Papadopoulos, Joel Martin, Qin Ruan, Ashique Rafique, Michael P Rosconi, Ergang Shi, Erica A Pyles, George D Yancopoulos, Neil Stahl, Stanley J Wiegand. Angiogenesis 2012
635
8

Sustained delivery fluocinolone acetonide vitreous inserts provide benefit for at least 3 years in patients with diabetic macular edema.
Peter A Campochiaro, David M Brown, Andrew Pearson, Sanford Chen, David Boyer, Jose Ruiz-Moreno, Bruce Garretson, Amod Gupta, Seenu M Hariprasad, Clare Bailey,[...]. Ophthalmology 2012
300
8

Disorganization of the retinal inner layers as a predictor of visual acuity in eyes with center-involved diabetic macular edema.
Jennifer K Sun, Michael M Lin, Jan Lammer, Sonja Prager, Rutuparna Sarangi, Paolo S Silva, Lloyd Paul Aiello. JAMA Ophthalmol 2014
227
8

Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results.
Daniel F Martin, Maureen G Maguire, Stuart L Fine, Gui-shuang Ying, Glenn J Jaffe, Juan E Grunwald, Cynthia Toth, Maryann Redford, Frederick L Ferris. Ophthalmology 2012
8


Long-term benefit of sustained-delivery fluocinolone acetonide vitreous inserts for diabetic macular edema.
Peter A Campochiaro, David M Brown, Andrew Pearson, Thomas Ciulla, David Boyer, Frank G Holz, Michael Tolentino, Amod Gupta, Lilianne Duarte, Steven Madreperla,[...]. Ophthalmology 2011
243
7

Outcomes with As-Needed Ranibizumab after Initial Monthly Therapy: Long-Term Outcomes of the Phase III RIDE and RISE Trials.
David S Boyer, Quan Dong Nguyen, David M Brown, Karen Basu, Jason S Ehrlich. Ophthalmology 2015
92
7

Randomized Trial of Treat and Extend Ranibizumab with and without Navigated Laser for Diabetic Macular Edema: TREX-DME 1 Year Outcomes.
John F Payne, Charles C Wykoff, W Lloyd Clark, Beau B Bruce, David S Boyer, David M Brown. Ophthalmology 2017
48
14

One-year outcomes of the da Vinci Study of VEGF Trap-Eye in eyes with diabetic macular edema.
Diana V Do, Quan Dong Nguyen, David Boyer, Ursula Schmidt-Erfurth, David M Brown, Robert Vitti, Alyson J Berliner, Bo Gao, Oliver Zeitz, Rene Ruckert,[...]. Ophthalmology 2012
256
7

Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: three-year randomized trial results.
Michael J Elman, Haijing Qin, Lloyd Paul Aiello, Roy W Beck, Neil M Bressler, Frederick L Ferris, Adam R Glassman, Raj K Maturi, Michele Melia. Ophthalmology 2012
259
7

Diabetic retinopathy.
Ning Cheung, Paul Mitchell, Tien Yin Wong. Lancet 2010
7


Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.
L P Aiello, R L Avery, P G Arrigg, B A Keyt, H D Jampel, S T Shah, L R Pasquale, H Thieme, M A Iwamoto, J E Park. N Engl J Med 1994
7

The REVEAL Study: Ranibizumab Monotherapy or Combined with Laser versus Laser Monotherapy in Asian Patients with Diabetic Macular Edema.
Tatsuro Ishibashi, Xiaoxin Li, Adrian Koh, Timothy Y Y Lai, Fenq-Lih Lee, Won-Ki Lee, Zhizhong Ma, Masahito Ohji, Nikolle Tan, Sung Bok Cha,[...]. Ophthalmology 2015
96
7


Diabetic retinopathy.
David A Antonetti, Ronald Klein, Thomas W Gardner. N Engl J Med 2012
976
7

Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant.
Joan-En Chang-Lin, Mayssa Attar, Andrew A Acheampong, Michael R Robinson, Scott M Whitcup, Baruch D Kuppermann, Devin Welty. Invest Ophthalmol Vis Sci 2011
344
7

Five-Year Outcomes after Initial Aflibercept, Bevacizumab, or Ranibizumab Treatment for Diabetic Macular Edema (Protocol T Extension Study).
Adam R Glassman, John A Wells, Kristin Josic, Maureen G Maguire, Andrew N Antoszyk, Carl Baker, Wesley T Beaulieu, Michael J Elman, Lee M Jampol, Jennifer K Sun. Ophthalmology 2020
23
30

Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales.
C P Wilkinson, Frederick L Ferris, Ronald E Klein, Paul P Lee, Carl David Agardh, Matthew Davis, Diana Dills, Anselm Kampik, R Pararajasegaram, Juan T Verdaguer. Ophthalmology 2003
7



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.